Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy
- 14 August 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (5) , 53-56
- https://doi.org/10.1016/0002-9149(87)90526-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.Circulation, 1985
- Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.Circulation, 1984
- Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failureAmerican Heart Journal, 1984
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Importance of Left Ventricular Chamber Size in Determining the Response to Hydralazine in Severe Chronic Heart FailureNew England Journal of Medicine, 1980
- The use of single plane angiocardiograms for the calculation of left ventricular volume in manAmerican Heart Journal, 1968
- A Method for Determining Left Ventricular Mass in ManCirculation, 1964
- The Effects of Intravenous Apresoline (Hydralazine) on Cardiovascular and Renal Function in Patients with and without Congestive Heart FailureCirculation, 1956